Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4778562
Max Phase: Preclinical
Molecular Formula: C44H55N11O9
Molecular Weight: 881.99
Molecule Type: Unknown
Associated Items:
ID: ALA4778562
Max Phase: Preclinical
Molecular Formula: C44H55N11O9
Molecular Weight: 881.99
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(N)=O
Standard InChI: InChI=1S/C44H55N11O9/c45-16-6-5-11-33(41(61)53-34(17-24-12-14-27(57)15-13-24)42(62)55-37(23-56)39(48)59)51-43(63)36(19-26-22-50-32-10-4-2-8-29(26)32)54-44(64)35(52-40(60)30(46)20-38(47)58)18-25-21-49-31-9-3-1-7-28(25)31/h1-4,7-10,12-15,21-22,30,33-37,49-50,56-57H,5-6,11,16-20,23,45-46H2,(H2,47,58)(H2,48,59)(H,51,63)(H,52,60)(H,53,61)(H,54,64)(H,55,62)/t30-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: RRFIGBGLRVMLOK-BPAOWUMVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 881.99 | Molecular Weight (Monoisotopic): 881.4184 | AlogP: -1.38 | #Rotatable Bonds: 24 |
Polar Surface Area: 355.76 | Molecular Species: BASE | HBA: 11 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.42 | CX Basic pKa: 10.18 | CX LogP: -2.68 | CX LogD: -4.47 |
Aromatic Rings: 5 | Heavy Atoms: 64 | QED Weighted: 0.03 | Np Likeness Score: 0.22 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):